Von-Hevesy-Str. 3
63128 Dietzenbach
Germany
Phone: +49 6074 401-0
Fax: +49 6074 401-221
http://www.diasorin.com
info@diasorin.de
Manufacturers
Company Contacts
Department/ Name Address
Rita Graf DiaSorin Deutschland GmbH, Von-Hevesy-Straße 3, D-63128 Dietzenbach, Telefon: +49 (6074) 40 14 00, Telefax: +49 (6074) 40 14 20, www.diasorin.com
info@DiaSorin.de
Company Figures
Number of employees 1-19
Sales volume 10-49 Mio US $
Export content max. 25%
Year of foundation 2003
Area of business Diagnostics
Language: German Language: English Company Profile
Company
Company description
DiaSorin S.p.A. is now a private company
DiaSorin S.p.A. originated as a diagnostic division of Sorin Biomedica S.p.A. and is today a private company that develops and manufactures reagents for in vitro diagnostics. With a large catalog of high quality products in the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity, DiaSorin is dedicated to improving the quality of life by way of assays that allow improved diagnostic decision. DiaSorin’s objective is to strengthen its presence in the global diagnostics market by focusing and responding to the changing customers and market needs.
The company is expanding
The company business is growing rapidly by means of natural expansion and acquisitions. With a commitment to a bold development strategy for premium products, DiaSorin is penetrating into new market segments. DiaSorin’s team has now over 700 employees. International contacts with the world’s leading scientists and universities are maintained and updated through ongoing Research and Development programs employing over 80 scientists.
DiaSorin sells its products worldwide directly through 11 subsidiaries and branch offices and as well as through an international network of over 80 distributors. In 2003, sales in Italy and the USA each represented 25% of the total company sales, the rest of Europe (Germany, France, Spain, Belgium, UK, Holland and Sweden) was 25%, Brazil was 5% and distributor sales in the rest of the world were 17% of the total.
Headquarters are in Saluggia
DiaSorin corporate headquarters are in Saluggia, Italy, where the main production site, marketing and research and development activities reside. Two additional production sites are located in Stillwater, Minnesota USA, and in Dietzenbach, Germany. All sites are ISO and/or FDA certified. The company’s newest instrument, the LIAISON®, uses proven state-of-the-art chemiluminescence and magnetic microparticle technologies with a large menu now approaching 70 assays.
Recently, DiaSorin has acquired a new technology (OCEAN) to identify single nucleotide mutations (SNPs) on genetic material extracted from blood or tissues.